“…Few authors have specifically explored the impact of illness duration on sexspecific findings, and SHIP data provide this opportunity. We chose five years postfirst-episode as a cut-off point for our examination into duration of illness, as previous research has suggested that early intervention (during the first five years after a first episode) is effective in reducing symptom severity and improving prognosis in many domains, especially in terms of motivation and positive symptoms (Agius, 2009;Agius et al, 2010;Agius et al, 2009;Amminger et al, 2011;Bird et al, 2010;Birnbaum et al, 2015;Cabral and Chaves, 2010;Chen et al, 2011;Coentre et al, 2011;Cotton et al, 2011;Gleeson et al, 2009;Henry et al, 2010;Liu et al, 2010;Marshall and Rathbone, 2011;Norman et al, 2015;Norman et al, 2012;Porter, 2012;Restek-Petrovic et al, 2012;Shrivastava et al, 2012;Srihari et al, 2012;Theodore et al, 2012), and these findings continue to be replicated and debated (Carrión et al, 2017;Castle and Singh, 2015;Chong et al, 2016;Conrad et al, 2014;Ehmann et al, 2014;Galletly et al, 2016;Hahn et al, 2016;Howes et al, 2016;Hughes et al, 2014;Joyce et al, 2016;Lambert et al, 2016;Laurens et al, 2015;Lower et al, 2015;Marshall et al, 2015;…”